186 related articles for article (PubMed ID: 29202210)
1. Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS.
Burchall GF; Piva TJ; Ranasinha S; Teede HJ
Thromb Haemost; 2017 Nov; 117(11):2053-2062. PubMed ID: 29202210
[No Abstract] [Full Text] [Related]
2. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
3. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
[TBL] [Abstract][Full Text] [Related]
4. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
5. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Sahu A; Tripathy P; Mohanty J; Nagy A
J Gynecol Obstet Hum Reprod; 2019 May; 48(5):335-339. PubMed ID: 30316907
[TBL] [Abstract][Full Text] [Related]
6. Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Luque-Ramírez M; Mendieta-Azcona C; del Rey Sánchez JM; Matíes M; Escobar-Morreale HF
Eur J Endocrinol; 2009 Mar; 160(3):469-80. PubMed ID: 19139031
[TBL] [Abstract][Full Text] [Related]
7. Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
Altinok ML; Ravn P; Andersen M; Glintborg D
Gynecol Endocrinol; 2018 Oct; 34(10):859-863. PubMed ID: 29658344
[TBL] [Abstract][Full Text] [Related]
8. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Kebapcilar L; Taner CE; Kebapcilar AG; Alacacioglu A; Sari I
Arch Gynecol Obstet; 2010 Jan; 281(1):35-42. PubMed ID: 19330342
[TBL] [Abstract][Full Text] [Related]
9. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
Meyer C; McGrath BP; Teede HJ
Diabetes Care; 2007 Mar; 30(3):471-8. PubMed ID: 17327307
[TBL] [Abstract][Full Text] [Related]
10. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Assessment of the Hemostatic System in Polycystic Ovarian Syndrome.
Burchall GF; Piva TJ; Linden MD; Gibson-Helm ME; Ranasinha S; Teede HJ
Semin Thromb Hemost; 2016 Feb; 42(1):55-62. PubMed ID: 26595150
[TBL] [Abstract][Full Text] [Related]
12. Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.
Fruzzetti F; Ghiadoni L; Virdis A; De Negri F; Perini D; Bucci F; Giannarelli C; Gadducci A; Taddei S
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):489-495. PubMed ID: 27018756
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women.
Yousuf SD; Ganie MA; Urwat U; Andrabi SM; Zargar MA; Dar MA; Manzoor-Ul-Rehman M; Mudassar S; Rashid F
BMC Womens Health; 2023 Feb; 23(1):68. PubMed ID: 36793022
[TBL] [Abstract][Full Text] [Related]
14. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
Moran LJ; Meyer C; Hutchison SK; Zoungas S; Teede HJ
J Endocrinol Invest; 2010 Apr; 33(4):258-65. PubMed ID: 19834313
[TBL] [Abstract][Full Text] [Related]
15. The treatment of polycystic ovary syndrome.
Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
[TBL] [Abstract][Full Text] [Related]
16. Menstrual cyclicity post OC withdrawal in PCOS: Use of non-hormonal options.
Kulshreshtha B; Arora A; Pahuja I; Sharma N; Pant S
J Obstet Gynaecol; 2016 Aug; 36(6):833-838. PubMed ID: 26982394
[TBL] [Abstract][Full Text] [Related]
17. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
[TBL] [Abstract][Full Text] [Related]
18. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial.
Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF
Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358
[TBL] [Abstract][Full Text] [Related]
19. The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
Pedersen AJT; Stage TB; Glintborg D; Andersen M; Christensen MMH
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):239-244. PubMed ID: 28834135
[TBL] [Abstract][Full Text] [Related]
20. A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Li J; Ren J; Sun W
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():13-21. PubMed ID: 27923166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
